Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Critical to make a clear distinction between NSQ and Spurious Drugs: IPA
The association claims that the media has interchanged the terms “Not of Standard Quality” and “Spurious” in reports about a CDSCO…
Alkem Laboratories denies claims of substandard quality for Pan-D and Clavam 625
Company asserts that reported samples are spurious and not manufactured by Alkem
Lupin partners with Celnova Pharma to distribute NaMuscla in Argentina and Colombia
NaMuscla (mexiletine) to be commercialised for the treatment of non-dystrophic myotonic disorders in adults
Alembic Pharmaceuticals receives U.S. FDA approval for Paliperidone extended-release tablets
Approval covers Paliperidone tablets for the treatment of schizophrenia and schizoaffective disorder
USV launches Quinidine Sulphate tablets to address rare heart arrhythmia
Q-rite tablets to provide treatment for irregular heartbeat conditions in select patients
Biocon signs licensing agreement with Tabuk Pharmaceuticals for GLP-1 products
Partnership aims to commercialise diabetes and weight management treatments in select Middle Eastern countries
10th Annual Pharma Legal & Compliance Summit to be held in Mumbai
Summit to address regulatory insights, legal updates, and compliance challenges in the pharmaceutical and healthcare sectors
Sun Pharma presents key dermatology data at EADV Congress in Amsterdam
Sun Pharmaceutical Industries announces presentations on deuruxolitinib and tildrakizumab at the 33rd European Academy of…
50 new pharma plants under PLI scheme to be completed in two years
India's pharma and medical device exports driven by PLI plants and regulatory reforms, says Dr Arunish Chawla at ASSOCHAM Annual…
Bhushan Akshikar appointed OPPI President
Current President Suresh Pattathil, Managing Director and General Manager, AbbVie India passes the baton on to Bhushan Akshikar